RESTASIS MULTIDOSE Trademark

Trademark Overview

On Wednesday, October 26, 2016, a trademark application was filed for RESTASIS MULTIDOSE with the United States Patent and Trademark Office. The USPTO has given the RESTASIS MULTIDOSE trademark a serial number of 87216956. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Sunday, February 12, 2023. This trademark is owned by Allergan, Inc.. The RESTASIS MULTIDOSE trademark is filed in the Pharmaceutical Products category with the following description:

Bottles sold as a unit filled with ophthalmic preparations
restasis multidose

General Information

Serial Number87216956
Word MarkRESTASIS MULTIDOSE
Filing DateWednesday, October 26, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSunday, February 12, 2023
Registration Number5243078
Registration DateTuesday, July 11, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Goods and ServicesBottles sold as a unit filled with ophthalmic preparations
Disclaimer with Predetermined Text"MULTIDOSE"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 31, 2016
Primary Code005
First Use Anywhere DateFriday, February 24, 2017
First Use In Commerce DateFriday, February 24, 2017

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Sunday, February 12, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, February 12, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, February 12, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 27, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 6, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 5, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 5, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 4, 2017USE AMENDMENT FILED
Wednesday, May 31, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 4, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 18, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, January 15, 2017NON-FINAL ACTION E-MAILED
Sunday, January 15, 2017NON-FINAL ACTION WRITTEN
Saturday, January 14, 2017ASSIGNED TO EXAMINER
Monday, October 31, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 29, 2016NEW APPLICATION ENTERED

Related Keywords

multidose restasis ophthalmic preparations filled unit sold bottles